Evidence map›Paper›PMID 34410490›Full record

ArticleHuman genetics2022

A wide range of protective and predisposing variants in aggrecan influence the susceptibility for otosclerosis.

Allan Thomas Højland, Lisse J M Tavernier, Isabelle Schrauwen, Manou Sommen, Vedat Topsakal, Isabelle Schatteman, Ingeborg Dhooge, Alex Huber, Diego Zanetti, Henricus P M Kunst and 4 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Human genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Exploring the genetic landscape of otosclerosis: current understanding and future perspectives.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2025
    Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 6 countries.

Allan Thomas Højland *Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.ORCID http://orcid.org/0000-0003-0014-3004
Lisse J M Tavernier *Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium.ORCID http://orcid.org/0000-0003-3267-7844
Isabelle SchrauwenCenter for Statistical Genetics, Department of Neurology, Gertrude H. Sergievsky Center, Columbia University Medical Center, New York, NY, USA.ORCID http://orcid.org/0000-0001-7310-6082
Manou SommenCenter of Medical Genetics, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium.ORCID http://orcid.org/0000-0001-7051-6553
Vedat TopsakalDepartment of ORL and Head and Neck Surgery, Antwerp University Hospital, University of Antwerp, Edegem, Belgium.ORCID http://orcid.org/0000-0003-0416-4005
Isabelle SchattemanEuropean Institute for ORL, St-Augustinus Hospital Antwerp, Antwerp, Belgium.ORCID http://orcid.org/0000-0003-2887-5485
Ingeborg DhoogeDepartment of Otolaryngology, Ghent University Hospital, Ghent, Belgium.ORCID http://orcid.org/0000-0002-5915-1079
Alex HuberDepartment of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-8888-8483
Diego ZanettiDepartment of Clinical Sciences and Community Health, Audiology Unit, University of Milan, I.R.C.C.S. Fondazione "Cà Granda", Osp.Le Maggiore Policlinico, Milano, Italy.ORCID http://orcid.org/0000-0002-8116-4108
Henricus P M KunstDepartment of Otorhinolaryngology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.ORCID http://orcid.org/0000-0003-1162-6394
Alexander HoischenDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID http://orcid.org/0000-0002-8072-4476
Michael B PetersenDepartment of Clinical Medicine, Aalborg University, Aalborg, Denmark.ORCID http://orcid.org/0000-0003-0316-8207
Guy Van Camp *Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium. guy.vancamp@uantwerpen.be.ORCID http://orcid.org/0000-0001-5105-9000
Erik Fransen *Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium. erik.fransen@uantwerpen.be.ORCID http://orcid.org/0000-0001-7785-4790
University of Antwerp · BEAalborg University Hospital · DKRadboud University Nijmegen · NLColumbia University Irving Medical Center · USFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITGhent University Hospital · BEUniversity Hospital of Zurich · CH

Funding

Belgian Federal Science Policy Office IAP P7/43-BeMGI
6 · The paper itself

Abstract

In this study, we investigated the association of ACAN variants with otosclerosis, a frequent cause of hearing loss among young adults. We sequenced the coding, 5'-UTR and 3'-UTR regions of ACAN in 1497 unrelated otosclerosis cases and 1437 matched controls from six different subpopulations. The association between variants in ACAN and the disease risk was tested through single variant and gene-based association tests. After correction for multiple testing, 14 variants were significantly associated with otosclerosis, ten of which represented independent association signals. Eight variants showed a consistent association across all subpopulations. Allelic odds ratios of the variants identified four predisposing and ten protective variants. Gene-based tests showed an association of very rare variants in the 3'-UTR with the phenotype. The associated exonic variants are all located in the CS domain of ACAN and include both protective and predisposing variants with a broad spectrum of effect sizes and population frequencies. This includes variants with strong effect size and low frequency, typical for monogenic diseases, to low effect size variants with high frequency, characteristic for common complex traits. This single-gene allelic spectrum with both protective and predisposing alleles is unique in the field of complex diseases. In conclusion, these findings are a significant advancement to the understanding of the etiology of otosclerosis.

Indexed as

Otosclerosis3' Untranslated Regions5' Untranslated RegionsAggrecansDisease SusceptibilityGene FrequencyGenetic Predisposition to DiseaseHumansPhenotypePolymorphism, Single Nucleotide3' Untranslated Regions5' Untranslated RegionsAggrecans

Identifiers

PMID34410490
OpenAlexW3195745380

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.